Literature DB >> 2646155

Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy.

B A Lessey1, D A Metzger, A F Haney, K S McCarty.   

Abstract

Estrogen receptors (ER) and progesterone receptors (PgR) in 19 endometriotic implants from 16 normally cycling and hormonally treated women were measured using immunohistochemical techniques and compared with 34 samples of normal intrauterine endometrium. Endometriotic implants contained specific ER and PgR in both glandular epithelium and stroma. In contrast to intrauterine endometrium, receptor content among implants was noted to be more heterogeneous, and did not undergo predictable changes in response to endogenous hormones. In the endometriotic implants of patients treated with hormonal therapy, there were significant decreases in ER and PgR in both the glands and stroma relative to untreated patients. These data imply that endometriosis is unpredictable in its response to the cyclic hormonal milieu in terms of ER and PgR, but retains the ability to respond to hormonal suppression over a prolonged interval.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2646155     DOI: 10.1016/s0015-0282(16)60545-9

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  20 in total

1.  Immunohistochemical detection of estrogen and progesterone receptors in endometriotic tissue. A comparative study of paraffin embedded and fresh frozen tissues.

Authors:  P A Regidor; M Regidor; K A Metz; A E Schindler
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344

2.  Quantitative enzyme immunoassay and semiquantitative immunohistochemistry of oestrogen and progesterone receptors in endometriotic tissue and endometrium.

Authors:  A Bergqvist; M Fernö; L Skoog
Journal:  J Clin Pathol       Date:  1997-06       Impact factor: 3.411

Review 3.  The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis.

Authors:  Sang Jun Han; Bert W O'Malley
Journal:  Hum Reprod Update       Date:  2014-03-14       Impact factor: 15.610

Review 4.  Does dienogest influence the inflammatory response of endometriotic cells? A systematic review.

Authors:  Giovanni Grandi; Michael Mueller; Nick A Bersinger; Angelo Cagnacci; Annibale Volpe; Brett McKinnon
Journal:  Inflamm Res       Date:  2015-12-09       Impact factor: 4.575

5.  Catechol-O-methyltransferase polymorphism and endometriosis.

Authors:  Fritz Wieser; Rene Wenzl; Clemens Tempfer; Christoph Worda; Johannes Huber; Christian Schneeberger
Journal:  J Assist Reprod Genet       Date:  2002-07       Impact factor: 3.412

6.  Laparoscopic treatment of deep infiltrating endometriosis: results of the combined laparoscopic gynecologic and colorectal surgery.

Authors:  Stefano Rausei; Daniele Sambucci; Sebastiano Spampatti; Elisa Cassinotti; Gianlorenzo Dionigi; Giulia David; Fabio Ghezzi; Stefano Uccella; Luigi Boni
Journal:  Surg Endosc       Date:  2014-12-09       Impact factor: 4.584

7.  Progesterone Receptor Status Predicts Response to Progestin Therapy in Endometriosis.

Authors:  Valerie A Flores; Arne Vanhie; Tran Dang; Hugh S Taylor
Journal:  J Clin Endocrinol Metab       Date:  2018-12-01       Impact factor: 5.958

Review 8.  The role of lipoxin A4 in endometrial biology and endometriosis.

Authors:  G O Canny; B A Lessey
Journal:  Mucosal Immunol       Date:  2013-03-13       Impact factor: 7.313

Review 9.  Medical management of endometriosis: emerging evidence linking inflammation to disease pathophysiology.

Authors:  K L Bruner-Tran; J L Herington; A J Duleba; H S Taylor; K G Osteen
Journal:  Minerva Ginecol       Date:  2013-04

Review 10.  Endometrial biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Devashana Gupta; M Louise Hull; Ian Fraser; Laura Miller; Patrick M M Bossuyt; Neil Johnson; Vicki Nisenblat
Journal:  Cochrane Database Syst Rev       Date:  2016-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.